Wangjun Liao, Min Shi, Xiaoxiang Rong, Siting Zheng, Shaowei Li, Weiwei Peng, Xiangcai Wang, Xia Yuan, Wei Zeng, Chunlin Wang, Qiong Deng, Futing Zhang, Huiyan Luo, Xin Wang. "Fruquintinib alternating with bevacizumab plus capecitabine as maintenance therapy after first-line treatment in metastatic colorectal cancer (mCRC): A multicenter, open-label, phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e15539